Pliant Therapeutics (PLRX) EPS (Basic) (2019 - 2026)
Pliant Therapeutics (PLRX) posted quarterly EPS (Basic) of -$0.93 for Q1 2026, up 5.22% year-over-year from -$0.88 in Q1 2025, and down 279.03% quarter-over-quarter from -$0.24 in Q4 2025.
Pliant Therapeutics (PLRX) EPS (Basic) (2019 - 2026) Analysis & Trends
Pliant Therapeutics (PLRX) has reported EPS (Basic) for 8 consecutive years, with -$0.93 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) rose 5.22% year-over-year to -$0.93; the TTM figure through Mar 2026 stood at -$3.04 (up 21.89% YoY), while the FY2025 annual figure was -$6.1, up 13.45% from the prior year.
- EPS (Basic) fell to -$0.93 in Q1 2026 per PLRX's latest filing, from -$0.24 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.24 in Q4 2025 and bottomed at -$1.41 in Q2 2025.
- Historically, EPS (Basic) has averaged -$0.83 across 5 years, with a median of -$0.83 in 2022.
- Annual changes were most pronounced in 2024 — EPS (Basic) sank 46.63% — and 2025, when it jumped 73.08%.
- Pliant Therapeutics' EPS (Basic) stood at -$0.83 in 2022, then retreated by 28.34% to -$1.07 in 2023, then grew by 15.13% to -$0.91 in 2024, then surged by 73.08% to -$0.24 in 2025, then slumped by 279.03% to -$0.93 in 2026.
- Business Quant data shows PLRX's EPS (Basic) at -$0.93 in Q1 2026, -$0.24 in Q4 2025, and -$0.47 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.23 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.06 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.18 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -0.72 |
| 10 | Pliant Therapeutics | 70.59 Mn | 70.59 Mn | - | -0.36 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.36 |
| Mar 31, 2026 | -0.93 |
| Dec 31, 2025 | -0.24 |
| Sep 30, 2025 | -0.47 |
| Jun 30, 2025 | -1.41 |
| Mar 31, 2025 | -0.98 |
| Dec 31, 2024 | -0.91 |
| Sep 30, 2024 | -1.01 |
| Jun 30, 2024 | -1.02 |
| Mar 31, 2024 | -0.89 |
| Dec 31, 2023 | -1.07 |
| Sep 30, 2023 | -0.70 |
| Jun 30, 2023 | -0.70 |
| Mar 31, 2023 | -0.67 |
| Dec 31, 2022 | -0.83 |
| Sep 30, 2022 | -0.65 |
| Jun 30, 2022 | -0.82 |
| Mar 31, 2022 | -0.78 |
| Dec 31, 2021 | -0.68 |
| Sep 30, 2021 | -0.75 |